Feed Preview

Mitochondria & Cholesterol in ND

Mitochondria & Cholesterol in ND diagram by Khan et al, PLOS One
Khan et al, PLOS One

This feed focuses on the role of the mitochondria and cholesterol on neurodevelopmental disorders (ND).

Top 20 most recent papers
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology

Transcriptional coactivator with PDZ-binding motif suppresses the expression of steroidogenic enzymes by nuclear receptor 4 A1 in Leydig cells

FASEB Journal : Official Publication of the Federation of American Societies for Experimental BiologyFebruary 19, 2020
Ji Hyun ShinEun Sook Hwang
Journal of Medicinal Chemistry

Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder

Journal of Medicinal ChemistryJanuary 18, 2020
Patrick SchniderChristophe Grundschober
22
Journal of Cachexia, Sarcopenia and Muscle

Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway

Journal of Cachexia, Sarcopenia and MuscleFebruary 1, 2020
Yasuhiro NishidaKazuyuki Tobe
20
Antioxidants & Redox Signaling

Inflammation, lipid (per)oxidation and redox regulation

Antioxidants & Redox SignalingJanuary 29, 2020
Irundika DiasH R Griffiths
2
Current Alzheimer Research

A Protective Role of Translocator Protein in Alzheimer's Disease Brain

Current Alzheimer ResearchFebruary 18, 2020
Marianna E Jung
1
Klinische Monatsblätter für Augenheilkunde

Secondary Neuroprotection in Glaucoma Through the Concepts of Complementary Drug Therapy

Klinische Monatsblätter für AugenheilkundeFebruary 11, 2020
Carl Erb
Environmental Science and Pollution Research International

Protective effects of quercetin against oxidative stress induced by bisphenol-A in rat cardiac mitochondria

Environmental Science and Pollution Research InternationalFebruary 18, 2020
Atefeh Raesi VananiMohammad Amin Dehghani
Journal of Inherited Metabolic Disease

Nanoparticles containing β-cyclodextrin potentially useful for the treatment of Niemann-Pick C

Journal of Inherited Metabolic DiseaseJanuary 17, 2020
Bruna DonidaCarmen R Vargas
3
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids

Endothelial lipase increases eNOS activating capacity of high-density lipoprotein

Biochimica Et Biophysica Acta. Molecular and Cell Biology of LipidsJanuary 11, 2020
Snježana RadulovićSaša Frank
1
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology

Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and PharmacologyJanuary 31, 2020
Alessandra MingionePaola Signorelli

See more papers from this feed

Related Feeds

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/mitochondria-cholesterol-in-nd/fcc4bd56-1fd7-4319-943b-748865a73130